Insulinemia and metabolic syndrome in a population of french soldiers (EPIMIL study);Insulinémie et paramètres du syndrome métabolique dans une population de militaires français (étude EPIMIL)

Immuno-Analyse et Biologie Specialisee

Volumn 20, Issue 5, 2005, Pages 291-294

  Bigaillon, C ^a   Chellak, S ^a   Ceppa, F ^a   Mayaudon, H ^a   Dupuy, O ^a   Garcia, C ^a   Baigts, F ^b   Bauduceau, B ^a   Burnat, P ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b Laboratoire MSD Chibret   (France)

Author keywords

Hyperinsulinemia; Insuline resistance; Metabolic syndrome

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SOLDIER; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 26444465094     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2005.05.004     Document Type: Article

References (14)

1. J. Ascaso, P. Romero, J. Real, R. Lorente, J. Martinez-Valls, and R. Carmena Abdominal obesity, insulin resistance, and the metabolic syndrome in a southern European population Eur. J. Int. Med. 14 2003 101 106
2. B. Balkau, M. Vernay, L. Mhamdi, M. Novak, D. Arondel, and S. Vol The incidence and the persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study Diabetes Metab. 29 2003 526 532
3. B. Bauduceau, F. Baigts, H. Mayaudon, P. Burnat, F. Ceppa, and O. Dupuy Les premiers ŕsultats d'EPIMIL:: ́tude ́pid́miologique des facteurs de risque et du syndrome ḿtabolique en milieu militaire Diabetes Metab. 30 2004 1S9 1S28
4. Consultation WHO Definition, diagnosis and classification of diabetes mellitus and its complications. Part I, Diagnosis and classification of diabetes mellitus. World Health Organisation, non-communicable disease surveillance. Geneva 1999
5. European group for the study of insulin resistance (EGIR) Frequency of the WHO metabolic syndrome in European cohorts, and alternative definition of an insulin resistance syndrome Diabetes Metab. 28 2002 364 376
6. E. Ferrannini, and B. Balkau Insulin: in search of a syndrome Diabet. Med. 19 2002 724 729
7. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359
8. E.S. Ford, and W.H. Giles A comparison of the prevalence of the metabolic syndrome using two proposed definitions Diabetes Care 26 2003 575 581
9. I. Lemieux, A. Pascot, C. Couillard, B. Lamarche, A. Tchernof, and N. Almeras Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small dense LDL) in men Circulation 102 2000 179 184
10. C. Lorenzo, M. Okoloise, K. Williams, M. Stern, and S. Haffner The metabolic syndrome as predictor of type 2 diabetes. The San Anthonio Heart Study Diabetes Care 26 2003 3153 3159
11. F. Luyckx, and A. Scheen Le syndrome ḿtabolique:: comparaison des param̀tres biologiques dans diff́rentes d́finitions Immunol. biol. spec. 19 2004 188 194
12. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, and D.F. Teacher Homeostasis model assessment:: insulin resistance and β cell function from fasting plasma glucose and insulin concentration in man Diabetologia 28 1985 412 419
13. E. Moro, P. Gallina, M. Pais, G. Cazzolato, P. Alessandrini, and Bittolo-Bon Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with the 1999 World Health Organisation criteria for the classification of diabetes Metabolism 52 2003 616 619
14. Third report of the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report Circulation 106 2002 3143 3421